KATIE FORSMAN: Open Payments
NPI 1467619635 · COEUR D' ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 23 payments from 12 companies in 2025. Trend: 2023 $264 · 2024 $374 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $133 |
| Hologic Sales and Service, LLC | 2 | $120 |
| Sage Therapeutics, LLC | 4 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $53 |
| Exeltis, USA Inc. | 2 | $34 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Octapharma USA, Inc. | 1 | $22 |
| Teleflex LLC | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
Products named: MYFEMBREE, MYOSURE TISSUE REMOVAL DEVICE, ZURZUVAE, Mirena, SLYND, INJECTAFER, APTIMA, FIBRYGA.
Industry payments across ID — which companies pay providers there.
